Showing results (171-180 of 369) with videos related to
Sort By:
Pageof 37
Cancer Chemotherapy and Pharmacology|March 28, 2012
Population pharmacokinetic analysis of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in adult patients with solid tumorsAbdulateef O Aregbe, Eric A Sherer, Merrill J Egorin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 11, 2011
Practical approach for comparative analysis of multilesion molecular imaging using a semiautomated program for PET/CTJosef J Fox, Estelle Autran-Blanc, Michael J Morris, et al.The American Journal of Surgical Pathology|November 26, 2010
Prostate cancer topography and patterns of lymph node metastasisYuji Tokuda, Lauren J Carlino, Anuradha Gopalan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancerJohann S de Bono, Howard I Scher, R Bruce Montgomery, et al.Nature Medicine|July 3, 2013
ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN lossYu Chen, Ping Chi, Shira Rockowitz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
Phase I evaluation of J591 as a vascular targeting agent in progressive solid tumorsMichael J Morris, Neeta Pandit-Taskar, Chaitanya R Divgi, et al.Vaccine|April 20, 2005
A bivalent conjugate vaccine in the treatment of biochemically relapsed prostate cancer: a study of glycosylated MUC-2-KLH and Globo H-KLH conjugate vaccines given with the new semi-synthetic saponin immunological adjuvant GPI-0100 OR QS-21Susan F Slovin, Govind Ragupathi, Celina Fernandez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenograftsDavid B Solit, Fuzhong F Zheng, Maria Drobnjak, et al.Molecular Cancer|June 8, 2007
Identification of novel androgen receptor target genes in prostate cancerUnnati Jariwala, Jennifer Prescott, Li Jia, et al.BJU International|November 17, 2011
Locally advanced prostate cancer: a population-based study of treatment patternsWilliam T Lowrance, Elena B Elkin, David S Yee, et al.Pageof 37